AzTrials
AzTrials

Mental HealthCOMPASSNCT06840457

COMPASS: A Comprehensive Mobile Precision Approach for Scalable Solutions in Mental Health Treatment

A study testing Mindfulness + Tailored Messages, Mindfulness without Tailored Messages and Cognitive Behavioral Therapy (CBT) + Tailored Messages in people with Mental Health, run by University of Michigan at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mental Health
What is being tested?
Mindfulness + Tailored Messages, Mindfulness without Tailored Messages and Cognitive Behavioral Therapy (CBT) + Tailored Messages
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4,400 participants
Where
1 siteUnited States
Study dates
3 Feb 2025to 30 Apr 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Seeking mental health services from Michigan Medicine, University Health Services, or collaborative clinics and services.
  • Must have daily access to a smartphone version that is compatible with study activity trackers.
  • Understands English to enable consent and use of the MyDataHelps app and app-based interventions

Who cannot join

  • Self-reported or medical record indication of a current eating disorder
  • Unable to provide informed consent (e.g., cognitive or guardianship restrictions)
  • Scheduled outpatient mental health appointment is a pediatric appointment (even if age 18+)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Michigan

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: COMPASS: Comprehensive Mobile Precision Approach for Scalable Solutions in Mental Health Treatment

This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments.

Conditions
Mental Health
Being tested
Mindfulness + Tailored Messages, Mindfulness without Tailored Messages, Cognitive Behavioral Therapy (CBT) + Tailored Messages, Cognitive Behavioral Therapy (CBT) without Tailored Messages
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness + Tailored MessagesBehavioural

    Also called Mindfulness

    Tailored Messages (TM) Participants randomized to receive enhanced feedback will receive this feedback from the MyDataHelps study app. This includes varying types of text and visual feedback based on data collected through the app. Messages will be displayed to participants on a dashboard in the app or delivered via pop-up notifications. Participants will receive a combination of text and visual messages.

    The study will use an app designed to train the user in mindfulness practices.

  • Mindfulness without Tailored MessagesBehavioural

    Also called Mindfulness

    The study will use an app designed to train the user in mindfulness practices.

  • Cognitive Behavioral Therapy (CBT) + Tailored MessagesBehavioural

    Also called CBT

    Tailored Messages (TM) Participants randomized to receive enhanced feedback will receive this feedback from the MyDataHelps study app. This includes varying types of text and visual feedback based on data collected through the app. Messages will be displayed to participants on a dashboard in the app or delivered via pop-up notifications. Participants will receive a combination of text and visual messages.

    The study will use an app designed to deliver cognitive behavioral therapy.

  • Cognitive Behavioral Therapy (CBT) without Tailored MessagesBehavioural

    Also called CBT

    The study will use an app designed to deliver cognitive behavioral therapy.

Study groups in NCT06840457
Study groupRoleWhat they receive
Mindfulness with tailored messagesActive comparatorParticipants will receive an app-based intervention, tailored messages from the MyDataHelps study app, and activity tracker.
Receives: Behavioral: Mindfulness + Tailored Messages
Mindfulness without tailored messagesActive comparatorParticipants will receive an app-based intervention and standard feedback from activity tracker.
Receives: Behavioral: Mindfulness without Tailored Messages
Cognitive Behavioral Therapy (CBT) with tailored messagesActive comparatorParticipants will receive an app-based intervention, tailored messages from the MyDataHelps study app, and activity tracker.
Receives: Behavioral: Cognitive Behavioral Therapy (CBT) + Tailored Messages
Cognitive Behavioral Therapy (CBT) without tailored messagesActive comparatorParticipants will receive an app-based intervention and standard feedback from activity tracker.
Receives: Behavioral: Cognitive Behavioral Therapy (CBT) without Tailored Messages

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression as measured by the Patient Health Questionnaire 9(PHQ-9)

    The PHQ-9 is an instrument for screening, diagnosing, monitoring and measuring the severity of depression: The PHQ-9 incorporates self-report questions on 9 specific depression symptoms that align with the DSM-IV depression diagnostic criteria. PHQ-9 scores range from 0-27 and 27 indicates severe depression.

    Measured: From enrollment to the 6-week assessment.

  2. Anxiety as measured using the Generalized Anxiety Disorder 7-Item (GAD-7) Scale

    GAD-7 consists total score for the seven items ranges from 0 to 21. Scores of 5, 10, and 15 represent cut points for mild, moderate, and severe anxiety, respectively.

    Measured: From enrollment to the 6-week assessment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2025
  2. Study start3 Feb 2025
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion30 Apr 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
4,400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06840457
Sponsor's protocol ID
HUM00248932
Other IDs
1U01MH136025
Acronym
COMPASS
Status last verified
Jun 2026
First submitted
17 Feb 2025
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Shared within National Institute of Mental Health Data Archive via grant data collaborator core.

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness + Tailored Messages, Mindfulness without Tailored Messages and Cognitive Behavioral Therapy (CBT) + Tailored Messages in people with Mental Health, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression as measured by the Patient Health Questionnaire 9(PHQ-9) (time frame: From enrollment to the 6-week assessment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in